Peptide industry eyes multibillion-dollar payday under Trump - AFR
Кратко: Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners. At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.
🧭 Извлечение: ok
· confidence 90%
· диагностика
High confidence: full text extraction produced 471 characters.
High confidence: full text extraction produced 471 characters.
New York | Businesses tied to Robert F. Kennedy Jr’s Make America Healthy Again movement are poised to benefit from a regulatory overhaul in Washington, as companies aligned with his agenda emerge as its earliest winners.
At a two-day meeting at the US Food and Drug Administration last week, a Kennedy-backed advisory panel voted to broaden public access to a handful of drugs known as peptides, despite the agency’s scientific staff advising against it.
Financial Times